Wall Street Beat
Edwards Lifesciences’ Sapien sales grow 11.5% in Q1
Medtech giant Edwards Lifesciences (NYSE:EW) posted Street-beating figures for its 1st quarter, driven largely by growth in its transcatheter heart valves.
C.R. Bard blows away sales and earnings expectations in Q1
Zimmer beats The Street, alters 2014 forecast on Biomet buy
Vascular Solutions lowers 2014 forecast on higher legal fees
Vascular Solutions (NSDQ:VASC) wasn’t making friends on Wall Street this week after the company missed expectations for Q1 and lowered its forecast for the rest of the year.
Former Stryker marketing executive escapes jail sentence | Medtech Wall Street news for the week of Apr. 21, 2014
Listen to Stryker’s Q1 2014 earnings call
Recall charges continue to suck up Stryker’s profits
Intuitive Surgical sinks following rough Q1 report
Intuitive Surgical (NSDQ:ISRG) dropped more than 11% today as Wall Street reacted to the surgical systems maker’s disappointing 1st-quarter earnings.
Allergan resists $47B offer by swallowing poison pill
FDA clears Intuitive Surgical’s single-site da Vinci Sp robotic surgery system
Intuitive Surgical (NSDQ:ISRG) shares recouped some recent losses today after the medical device company announced 510(k) clearance from the FDA for its da Vinci Sp single-site robot-assisted surgery platform in urological procedures.